Pharming Group NV
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Pharming Group NV
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
/ 
Frequently asked questions
To buy Pharming Group NV stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Pharming Group NV by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Pharming Group NV is PHARM:xams. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Pharming Group NV has its primary listing on Euronext Amsterdam. You can trade Pharming Group NV with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Pharming Group NV is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Pharming Group NV as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Pharming Group NV .